Evidence map›Paper›PMID 28817050›Full record

ReviewMaterials (Basel, Switzerland)2012

Carbon Nanomaterials: Efficacy and Safety for Nanomedicine.

Takuya Yamashita, Kohei Yamashita, Hiromi Nabeshi, Tomoaki Yoshikawa, Yasuo Yoshioka, Shin-Ichi Tsunoda, Yasuo Tsutsumi

Open access · goldAbstract readReview
In one paragraph

Review in Materials (Basel, Switzerland), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 79 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Structural Study of Sulfur-Added Carbon Nanohorns.Materials (Basel, Switzerland) · 2022
    Article
  7. Article
  8. Effects of Aqueous Dispersions of CInternational journal of molecular sciences · 2021
    Article
  9. Article
  10. Carbon Nanomaterials for Sorption ofNanomaterials (Basel, Switzerland) · 2020
    Article
  11. Citric Juice-mediated Synthesis of Tellurium Nanoparticles with Antimicrobial and Anticancer Properties.Green chemistry : an international journal and green chemistry resource : GC · 2019
    Article
  12. Review
  13. Article
  14. Review
  15. Targeted therapy using nanotechnology: focus on cancer.International journal of nanomedicine · 2014
    Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Takuya YamashitaLaboratory of Toxicology and Safety Science, Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka 565-0871, Japan. t-yamashita@nibio.go.jp.
Kohei YamashitaLaboratory of Toxicology and Safety Science, Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka 565-0871, Japan. yamasita@phs.osaka-u.ac.jp.
Hiromi NabeshiLaboratory of Toxicology and Safety Science, Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka 565-0871, Japan. nabeshi@phs.osaka-u.ac.jp.
Tomoaki YoshikawaLaboratory of Toxicology and Safety Science, Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka 565-0871, Japan. tomoaki@phs.osaka-u.ac.jp.
Yasuo YoshiokaLaboratory of Toxicology and Safety Science, Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka 565-0871, Japan. yasuo@phs.osaka-u.ac.jp.
Shin-Ichi TsunodaLaboratory of Biopharmaceutical Research, National Institute of Biomedical Innovation, 7-6-8 Saito-Asagi, Ibaraki, Osaka 567-0085, Japan. tsunoda@nibio.go.jp.
Yasuo TsutsumiLaboratory of Toxicology and Safety Science, Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka 565-0871, Japan. ytsutsumi@phs.osaka-u.ac.jp.
Osaka University · JPNational Institute of Biomedical Innovation, Health and Nutrition · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carbon nanomaterials, including fullerenes, carbon nanohorns, and carbon nanotubes, are increasingly being used in various fields owing to these materials' unique, size-dependent functions and physicochemical properties. Recently, because of their high variability and stability, carbon nanomaterials have been explored as a novel tool for the delivery of therapeutic molecules including peptide and nucleic acid cancer drugs. However, insufficient information is available regarding the safety of carbon nanomaterials for human health, even though such information is vital for the development of safe and effective nanomedicine technologies. In this review, we discuss currently available information regarding the safety of carbon nanomaterials in nanomedicine applications, including information obtained from our own studies; and we discuss types of carbon nanomaterials that demonstrate particular promise for safe nanomedicine technologies.

Indexed as

carbon nanohornscarbon nanomaterialscarbon nanotubesdrug deliveryfullerenesnanomedicinenano safety science

Identifiers

PMID28817050
PMCPMC5448911
OpenAlexW1971858499

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.